XML 38 R24.htm IDEA: XBRL DOCUMENT v3.23.3
SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Aug. 31, 2023
Accounting Policies [Abstract]  
Disaggregation of Revenue
The components of disaggregation of revenue for the years ended August 31, 2023, 2022, and 2021 were as follows:
Years ended August 31,
(in thousands)202320222021
Software licenses
Point in time$35,369 $31,587 $26,725 
Over time1,148 1,055 945 
Services 
Over time23,060 21,264 18,796 
Total revenue$59,577 $53,906 $46,466 
Schedule of Geographical Revenues Geographical revenues for the years ended August 31, 2023, 2022, and 2021 were as follows:
Years ended August 31,
(in thousands)202320222021
$% of total $% of total $% of total
Americas$40,817 69 %$37,681 70 %$32,549 70 %
EMEA11,713 20 %10,388 19 %7,906 17 %
Asia Pacific7,047 12 %5,837 11 %6,011 13 %
Total$59,577 100 %$53,906 100 %$46,466 100 %
Accounts Receivable, Allowance for Credit Loss
The activity in the allowance for credit losses related to our trade receivables is summarized as follows:
Years ended August 31,
(in thousands)202320222021
Balance, beginning of period$12 $78 $50 
Provision for expected credit losses77 (66)28 
Write-offs(43)— — 
Balance, end of period$46 $12 $78 
Property and Equipment estimated useful lives Depreciation and amortization are calculated using the straight-line method over the estimated useful lives as follows:
Equipment5 years
Computer equipment
3 to 7 years
Furniture and fixtures
5 to 7 years
Leasehold improvementsShorter of the asset life or lease term
Lease, Cost
Supplemental balance sheet information related to operating leases was as follows as of August 31, 2023:
(in thousands)
Right of use assets$1,247 
Lease liabilities, current$442 
Lease liabilities, long-term$755 
Operating lease costs$463 
Weighted-average remaining lease term3.29 years
Weighted-average discount rate4.91 %
Schedule of Finite-Lived Intangible Assets
The following table summarizes other intangible assets as of August 31, 2023:
(in thousands)Amortization
Period		Acquisition
Value		Accumulated
Amortization		Net Book Value
Trade namesNone$4,210 $— $4,210 
Covenants not to compete
Straight line 2 to 3 years
30 3 27 
Other internal use software
Straight line 3 to 5 years
350 10 340 
Customer relationships
Straight line 8 to 14 years
8,230 1,887 6,343 
ERP
Straight line 15 years
2,112 207 1,905 
$14,932 $2,107 $12,825 
The following table summarizes other intangible assets as of August 31, 2022:
(in thousands)Amortization
Period		Acquisition
Value		Accumulated
Amortization		Net Book Value
Trade namesNone$2,910 $— $2,910 
Covenants not to compete
Straight line 3 years
60 48 12 
Customer relationships
Straight line 8 to 14 years
5,550 2,534 3,016 
ERP
Straight line 15 years
1,702 80 1,622 
$10,222 $2,662 $7,560 
Finite-lived Intangible Assets Amortization Expense
Estimated future amortization of finite-lived intangible assets for the next five years is as follows:
(in thousands)
Years ending August 31,
Amount
2024$960 
2025$957 
2026$945 
2027$898 
2028$755 
Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis
The following tables summarize our short-term investments as of August 31, 2023, and August 31, 2022:
August 31, 2023
(in thousands)Amortized CostGross
Unrealized
Gains		Gross
Unrealized
Losses		Fair Value
Commercial notes (due within one year)$53,940 $— $(115)$53,825 
Term deposits (due within one year)4,000 — — 4,000 
Total$57,940 $— $(115)$57,825 
August 31, 2022
(in thousands)Amortized CostGross
Unrealized
Gains		Gross
Unrealized
Losses		Fair Value
Commercial notes (due within one year)$72,168 $— $(839)$71,329 
Term deposits (due within one year)4,500 — — 4,500 
Total$76,668 $— $(839)$75,829 
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination
The following table summarizes intellectual property as of August 31, 2023:
(in thousands)Amortization
Period		Acquisition
Value		Accumulated
Amortization		Net Book
Value
Termination/nonassertion agreement-TSRL Inc.
Straight line 10 years
$6,000 $5,575 $425 
Developed technologies–DILIsym acquisition
Straight line 9 years
2,850 1,978 872 
Intellectual rights of Entelos Holding Company
Straight line 10 years
50 25 25 
Developed technologies–Immunetrics acquisition
Straight line 5 years
1,080 45 1,035 
Developed technologies–Lixoft acquisition
Straight line 16 years
8,010 1,678 6,332 
$17,990 $9,301 $8,689 
The following table summarizes intellectual property as of August 31, 2022:
(in thousands)Amortization
Period		Acquisition
Value		Accumulated
Amortization		Net Book
Value
Royalty Agreement buy out-Enslein Research
Straight line 10 years
$75 $75 $— 
Termination/nonassertion agreement-TSRL Inc.
Straight line 10 years
6,000 4,975 1,025 
Developed technologies–DILIsym acquisition
Straight line 9 years
2,850 1,662 1,188 
Intellectual rights of Entelos Holding Company
Straight line 10 years
50 20 30 
Developed technologies–Lixoft acquisition
Straight line 16 years
8,010 1,196 6,814 
$16,985 $7,928 $9,057 
The following table presents the details of intangible assets acquired.
Estimated useful lifeAmount
Indefinite-lived:
Trade namesIndefinite$1,800 
Definite-lived:
Customer relationships
9 years
3,780 
Developed technologies
5 years
1,080 
Covenants not to compete
2 years
30 
Total definite-lived intangible assets4,890 
Total intangible assets$6,690 
Schedule of Future Amortization Expenses
Estimated future amortization of intellectual property for the next five years is as follows:
(in thousands)
Years ending August 31,
Amount
2024$1,434 
2025$1,009 
2026$933 
2027$693 
2028$648 
Schedule of Earnings Per Share, Basic and Diluted The components of basic and diluted earnings per share for the years ended August 31, 2023, 2022, and 2021 were as follows:
Years ended August 31,
(in thousands)202320222021
Numerator
Net income attributable to common shareholders$9,961 $12,483 $9,782 
Denominator
Weighted-average number of common shares outstanding during the year20,075 20,196 20,045 
Dilutive effect of stock options390 553 698 
Common stock and common stock equivalents used for diluted earnings per share20,465 20,749 20,743 
Schedule of Goodwill
Reconciliation of Goodwill as of August 31, 2023, 2022, and 2021:
(in thousands)CognigenDILIsymLixoftImmunetricsTotal
Balance, August 31, 2021$4,789 $5,598 $2,534 $— $12,921 
Addition— — — — — 
Impairments— — — — — 
Balance, August 31, 20224,789 5,598 2,534 — 12,921 
Addition— — — 6,178 6,178 
Impairments— — — — — 
Balance, August 31, 2023$4,789 $5,598 $2,534 $6,178 $19,099 
Schedule of Business Acquisitions by Acquisition, Contingent Consideration
The following is a reconciliation of contingent consideration at fair value:
(in thousands)Amount
Contingent consideration at acquisition date4,100 
Change in fair value of contingent consideration680 
 Contingent consideration as of August 31, 2023$4,780